These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Methadone: friend or foe? Jackson WC Tenn Med; 2011 Apr; 104(4):39-41. PubMed ID: 21560909 [No Abstract] [Full Text] [Related]
23. Parenteral methadone: an essential medication for the treatment of pain. Manfredi PL; Foley KM; Payne R; Houde R; Inturrisi CE J Pain Symptom Manage; 2003 Aug; 26(2):687-8. PubMed ID: 12906950 [No Abstract] [Full Text] [Related]
24. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved? Cobos EJ; Baeyens JM J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240 [No Abstract] [Full Text] [Related]
25. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. Reddy S; Fisch M; Bruera E J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646 [No Abstract] [Full Text] [Related]
26. Switching from methadone to tapentadol for cancer pain. Mercadante S; Ferrera P; Adile C J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437 [No Abstract] [Full Text] [Related]
27. Opioid-sparing effect of diclofenac in cancer pain. Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838 [TBL] [Abstract][Full Text] [Related]
28. Opioid rotation to methadone at home. Hernansanz S; Gutiérrez C; Rubiales AS; Flores LA; del Valle ML J Pain Symptom Manage; 2006 Jan; 31(1):2-4. PubMed ID: 16442475 [No Abstract] [Full Text] [Related]
29. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone. Cruciani RA; Lussier D; Miller-Saultz D; Arbuck DM J Pain Symptom Manage; 2003 Jun; 25(6):491-4. PubMed ID: 12782427 [No Abstract] [Full Text] [Related]
30. Conversion from parenteral to oral methadone. González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849 [TBL] [Abstract][Full Text] [Related]
31. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer. Latuga NM; Wahler RG J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910 [TBL] [Abstract][Full Text] [Related]
32. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics. Leppert W; Kowalski G J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476 [No Abstract] [Full Text] [Related]
34. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. Salpeter SR; Buckley JS; Buckley NS; Bruera E J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475 [TBL] [Abstract][Full Text] [Related]
36. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Mercadante S Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828 [TBL] [Abstract][Full Text] [Related]
37. Methadone: the renaissance. Watanabe S J Palliat Care; 2001; 17(2):117-20. PubMed ID: 11477986 [No Abstract] [Full Text] [Related]
38. Treatment of acute pain in opioid tolerant patients. Bean HK; Gannon R Conn Med; 2010 Mar; 74(3):143-8. PubMed ID: 20391820 [No Abstract] [Full Text] [Related]
39. Methadone: a closer look at the controversy. Gaertner J; Voltz R; Ostgathe C J Pain Symptom Manage; 2008 Aug; 36(2):e4-7. PubMed ID: 18655953 [No Abstract] [Full Text] [Related]
40. An update on the clinical use of methadone for cancer pain. Ripamonti C; Zecca E; Bruera E Pain; 1997 Apr; 70(2-3):109-15. PubMed ID: 9150283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]